Codagenix

0 followers
‌

Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development.

Industries

Employees

11-50

Links


Org chart

Tyler Cook
Advisor, Finance
Gerard Cunningham
Operating Partner, Adjuvant Capital
Steffen Mueller
Founder, President, Chief Scientific Officer
Jeffrey Fu
Chief Business Officer

Board & advisors

Jill Howe
Director
Paul Grint
Director
Steven Burakoff
Scientific Advisor
Gavin Corcoran
Scientific Advisor
Wayne Koff
Scientific Advisor
Larry Norton
Scientific Advisor
George E. Peoples
Scientific Advisor
Stanley Plotkin
Scientific Advisor